FDA Orange Book · active-ingredient family
Divalproex sodium
Divalproex sodium is approved as 4 brand and 38 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DEPAKOTE ER · NDA 021168
4
Brand (NDA)
38
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, delayed rel pellets, tablet, delayed release, tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DEPAKOTE ERRLD×2 | ABBVIE | NDA 021168 | AB | May 31, 2002 | |
| DEPAKOTERLD | ABBVIE | NDA 019680 | AB | Sep 12, 1989 | |
| DEPAKOTERLD×3 | ABBVIE | NDA 018723 | AB | Oct 26, 1984 | |
| DEPAKOTE CP×2 | ABBOTT | NDA 019794 | — | Jul 11, 1990 |
Generic (ANDA) products (38)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DIVALPROEX SODIUM | MANKIND PHARMA | ANDA 217358 | AB | Aug 12, 2025 | |
| DIVALPROEX SODIUM | ALEMBIC | ANDA 218793 | AB | Dec 19, 2024 | |
| DIVALPROEX SODIUM×2 | ANNORA PHARMA | ANDA 215527 | AB | Sep 26, 2023 | |
| DIVALPROEX SODIUM×2 | UNICHEM | ANDA 214643 | AB | Feb 25, 2022 | |
| DIVALPROEX SODIUM×2 | YICHANG HUMANWELL | ANDA 214462 | — | Mar 15, 2021 | |
| DIVALPROEX SODIUM | TEVA PHARMS USA | ANDA 211505 | — | Nov 17, 2020 | |
| DIVALPROEX SODIUM | AJANTA PHARMA LTD | ANDA 213181 | AB | Mar 02, 2020 | |
| DIVALPROEX SODIUM×2 | LUPIN | ANDA 209286 | AB | Oct 18, 2019 | |
| DIVALPROEX SODIUM×2 | AMNEAL PHARMS | ANDA 203730 | AB | May 29, 2015 | |
| DIVALPROEX SODIUM×2 | AUROBINDO PHARMA LTD | ANDA 202419 | AB | Jun 02, 2014 | |
| DIVALPROEX SODIUM | DR REDDYS LABS LTD | ANDA 090161 | AB | Mar 15, 2012 | |
| DIVALPROEX SODIUM | REDDYS | ANDA 090070 | AB | Mar 12, 2012 | |
| DIVALPROEX SODIUM×3 | AUROBINDO PHARMA LTD | ANDA 090554 | AB | Apr 21, 2011 | |
| DIVALPROEX SODIUM×3 | UNICHEM LABS LTD | ANDA 079163 | AB | Apr 05, 2011 | |
| DIVALPROEX SODIUM | RISING | ANDA 090407 | — | Mar 28, 2011 | |
| DIVALPROEX SODIUM | ACTAVIS LABS FL INC | ANDA 079080 | — | Feb 25, 2011 | |
| DIVALPROEX SODIUM×3 | PRINSTON INC | ANDA 090210 | AB | Nov 30, 2009 | |
| DIVALPROEX SODIUM | COSETTE | ANDA 078700 | — | Aug 03, 2009 | |
| DIVALPROEX SODIUM×2 | IMPAX LABS | ANDA 078791 | — | May 06, 2009 | |
| DIVALPROEX SODIUM×3 | PHARMOBEDIENT | ANDA 090062 | — | Mar 17, 2009 | |
| DIVALPROEX SODIUM×3 | ZYDUS PHARMS USA INC | ANDA 077100 | AB | Mar 05, 2009 | |
| DIVALPROEX SODIUM×2 | ZYDUS PHARMS USA INC | ANDA 078239 | AB | Feb 27, 2009 | |
| DIVALPROEX SODIUM×2 | PH HEALTH | ANDA 078445 | — | Feb 26, 2009 | |
| DIVALPROEX SODIUM×2 | SCIEGEN PHARMS | ANDA 078705 | AB | Feb 10, 2009 | |
| DIVALPROEX SODIUM×2 | MYLAN | ANDA 077567 | AB | Jan 29, 2009 | |
| DIVALPROEX SODIUM | ZYDUS PHARMS USA INC | ANDA 078919 | AB | Jan 27, 2009 | |
| DIVALPROEX SODIUM | DR REDDYS LABS LTD | ANDA 078979 | AB | Jan 23, 2009 | |
| DIVALPROEX SODIUM×3 | ORBION PHARMS | ANDA 078853 | AB | Nov 25, 2008 | |
| DIVALPROEX SODIUM | PH HEALTH | ANDA 078411 | — | Nov 03, 2008 | |
| DIVALPROEX SODIUM×3 | CHARTWELL RX | ANDA 077296 | AB | Jul 31, 2008 | |
| DIVALPROEX SODIUM×3 | APOTEX | ANDA 077615 | — | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | DR REDDYS LABS LTD | ANDA 078755 | AB | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | INVATECH | ANDA 078290 | AB | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | LUPIN | ANDA 078790 | — | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | MYLAN | ANDA 077254 | — | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | SUN PHARM INDS | ANDA 078597 | AB | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | TEVA | ANDA 076941 | — | Jul 29, 2008 | |
| DIVALPROEX SODIUM×3 | UPSHER SMITH LABS | ANDA 078182 | AB | Jul 29, 2008 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Divalproex sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

